These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20880393)

  • 1. Control of vascular tone by purines and pyrimidines.
    Burnstock G
    Br J Pharmacol; 2010 Oct; 161(3):527-9. PubMed ID: 20880393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney.
    Tölle M; Schuchardt M; Wiedon A; Huang T; Klöckel L; Jankowski J; Jankowski V; Zidek W; van der Giet M
    Br J Pharmacol; 2010 Oct; 161(3):530-40. PubMed ID: 20880394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.
    Zhou Z; Matsumoto T; Jankowski V; Pernow J; Mustafa SJ; Duncker DJ; Merkus D
    Pharmacol Res; 2019 Mar; 141():32-45. PubMed ID: 30553823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic signaling and blood vessels in health and disease.
    Burnstock G; Ralevic V
    Pharmacol Rev; 2014; 66(1):102-92. PubMed ID: 24335194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic transmission in blood vessels.
    Ralevic V; Dunn WR
    Auton Neurosci; 2015 Sep; 191():48-66. PubMed ID: 26004513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purine nucleotides as regulators of vessel tone.
    Pearson JD
    Biochem Soc Trans; 1988 Aug; 16(4):480-2. PubMed ID: 3061848
    [No Abstract]   [Full Text] [Related]  

  • 7. Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.
    Jankowski V; van der Giet M; Mischak H; Morgan M; Zidek W; Jankowski J
    Br J Pharmacol; 2009 Aug; 157(7):1142-53. PubMed ID: 19563527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification.
    Schuchardt M; Tölle M; Prüfer J; Prüfer N; Huang T; Jankowski V; Jankowski J; Zidek W; van der Giet M
    Kidney Int; 2012 Feb; 81(3):256-65. PubMed ID: 21956191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uridine adenosine tetraphosphate affects contractility of mouse aorta and decreases blood pressure in conscious rats and mice.
    Hansen PB; Hristovska A; Wolff H; Vanhoutte P; Jensen BL; Bie P
    Acta Physiol (Oxf); 2010 Oct; 200(2):171-9. PubMed ID: 20384597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in P2-purinergic receptors on vascular smooth muscle and endothelium.
    Koga T; Takata Y; Kobayashi K; Fujii K; Nagao T; Fujishima M
    Hypertension; 1992 Mar; 19(3):286-9. PubMed ID: 1548053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.
    Matsumoto T; Goulopoulou S; Taguchi K; Tostes RC; Kobayashi T
    Br J Pharmacol; 2015 Aug; 172(16):3980-4001. PubMed ID: 26031319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual control of local blood flow by purines.
    Burnstock G
    Ann N Y Acad Sci; 1990; 603():31-44; discussion 44-5. PubMed ID: 2291529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of the endothelium in the regulation of vasomotor activity].
    Boulanger C; Vanhoutte PM
    Arch Mal Coeur Vaiss; 1991 Jan; 84 Spec No 1():35-44. PubMed ID: 2053832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic regulation of vascular tone and remodelling.
    Burnstock G
    Auton Autacoid Pharmacol; 2009 Jul; 29(3):63-72. PubMed ID: 19566746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diadenosine polyphosphates cause contraction and relaxation in isolated rat resistance arteries.
    Steinmetz M; Schlatter E; Boudier HA; Rahn KH; De Mey JG
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1175-81. PubMed ID: 10945874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uridine adenosine tetraphosphate is a novel vasodilator in the coronary microcirculation which acts through purinergic P1 but not P2 receptors.
    Zhou Z; Merkus D; Cheng C; Duckers HJ; Jan Danser AH; Duncker DJ
    Pharmacol Res; 2013 Jan; 67(1):10-7. PubMed ID: 23063485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diadenosine polyphosphates in cultured vascular smooth-muscle cells and endothelium cells--their interaction with specific receptors and their degradation.
    Verspohl EJ; Johannwille B; Kaiserling-Buddemeier I; Schlüter H; Hagemann J
    J Pharm Pharmacol; 1999 Oct; 51(10):1175-81. PubMed ID: 10579689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary vasomotor and cardiac electrophysiologic effects of diadenosine polyphosphates and nonhydrolyzable analogs in the guinea pig.
    Stavrou BM; Lawrence C; Blackburn GM; Cohen T; Sheridan DJ; Flores NA
    J Cardiovasc Pharmacol; 2001 May; 37(5):571-84. PubMed ID: 11336108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of endothelium-derived relaxing factor-mediated relaxation and smooth muscle cell function in arterial and venous vein bypass grafts.
    Davies MG; Klyachkin ML; Svendsen E; Hagen PO
    Cardiovasc Surg; 1996 Apr; 4(2):150-60. PubMed ID: 8861428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of angiotensin ii on vascular remodeling].
    Pueyo M; Michel JB
    Nephrologie; 1998; 19(7):443-9. PubMed ID: 9857382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.